Key points are not available for this paper at this time.
These data suggest that interactions between tumor and inflammatory cells may contribute to the clinical metastatic neuroblastoma phenotype, improve prognostication, and reveal novel therapeutic targets.
Asgharzadeh et al. (Tue,) studied this question.